1. Cystine supplementation rebalances the redox homeostasis of microenvironment in non-small cell lung cancer cells and reverses their resistance to docetaxel
   Si-jia Li et al, 2021, Acta Pharmacologica Sinica CrossRef
2. Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades
   Miglė Paškevičiūtė et al, 2019, Drug Delivery and Translational Research CrossRef
3. In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31
   Wenqin Sun et al, 2023, International Journal of Molecular Sciences CrossRef
4. A New Class of Gold(I) NHC Complexes with Proapoptotic and Resensitizing Properties towards Multidrug Resistant Leukemia Cells Overexpressing BCL-2
   Franziska Bannwart et al, 2024, Journal of Medicinal Chemistry CrossRef
5. Epigenetic regulation of stem cells in lung cancer oncogenesis and therapy resistance
   Jiayang Wu et al, 2023, Frontiers in Genetics CrossRef
6. A bioinformatics investigation into the pharmacological mechanisms of javanica oil emulsion injection in non-small cell lung cancer based on network pharmacology methodologies
   Mengwei Ni et al, 2020, BMC Complementary Medicine and Therapies CrossRef
7. Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer
   Hayrettin Tonbul et al, 2019, Journal of Drug Delivery Science and Technology CrossRef
8. Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations
   Hidejiro Torigoe et al, 2018, Cancer Science CrossRef
9. Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer
   Sadia Sarwar et al, 2024, Cell Death & Disease CrossRef
10. Discovery of a Flavonoid FM04 as a Potent Inhibitor to Reverse P-Glycoprotein-Mediated Drug Resistance in Xenografts and Improve Oral Bioavailability of Paclitaxel
    Jason W. Y. Kan et al, 2022, International Journal of Molecular Sciences CrossRef
11. Peptide-Conjugated Vascular Endothelial Extracellular Vesicles Encapsulating Vinorelbine for Lung Cancer Targeted Therapeutics
    Isha Gaurav et al, 2024, Nanomaterials CrossRef
12. Research progress on lung cancer stem cells in epidermal growth factor receptor–tyrosine kinase inhibitor targeted therapy resistance in lung adenocarcinoma
    Hong Zhang et al, 2024, Oncology and Translational Medicine CrossRef
13. Combination of Elacridar with Imatinib Modulates Resistance Associated with Drug Efflux Transporters in Chronic Myeloid Leukemia
    Raquel Alves et al, 2022, Biomedicines CrossRef
14. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions
    Urvi H. Gala et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
15. Cancer Stem Cells: Powerful Targets to Improve Current Anticancer Therapeutics
    Rayana L. Bighetti-Trevisan et al, 2019, Stem Cells International CrossRef
16. Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors
    Shuo Yuan et al, 2021, Journal of Medicinal Chemistry CrossRef
17. Effect of Polyamidoamine-Dendrimer Nanoparticles Combined with Human Umbilical Vein Endothelial Cell Microenvironment on the Growth and Immune Infiltration of Nasopharyngeal Carcinoma Cell Line CNE-1
    Wei Zhou et al, 2023, Science of Advanced Materials CrossRef